Philips/Biomerieux ink point-of-care test partnership
This article was originally published in The Gray Sheet
Executive Summary
Firms will jointly develop fully automated, handheld immunoassay diagnostics for hospitals based on Philips' Magnotech biosensor platform under a partnership announced Jan. 7. The initial "co-branded" products, intended to "improve diagnosis and disease management in critical care settings," are slated to debut by 2013 and will be distributed exclusively by Biomerieux, the firms say